Journal of Dali University ›› 2023, Vol. 8 ›› Issue (4): 64-68.

Previous Articles     Next Articles

Clinical Analysis of the Therapeutic Effect of Baylor Plaster Immobilization in the Treatment of Legg-Calve-Perthes Disease in Children

Gao Guoxi, Hu Jianhua, Yang Zhao, Zhang Jun, Zhang Chao   

  1. (1. Department of Orthopedics, Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, China; 2. Department of Orthopedics, The First People's Hospital of Yunnan Province, Kunming 650032, China)

  • Received:2020-07-27 Revised:2020-12-13 Online:2023-04-15 Published:2023-04-25

Abstract:

Objective: To analyze the clinical efficacy of Baylor plaster immobilization in the treatment of Legg-Calve-Perthes disease in children (hereinafter referred to as "Perthes disease"). Methods: Before treatment, 18 children with Perthes disease were classified by Catterall. After treatment, all children were followed up for at least 2 years. At the end of the follow-up, Stulberg classification evaluation and Harris score of hip joint were performed. Results: All the children began to receive treatment after the average diagnosis of (2.6±4.1) months, and the average time of Baylor plaster immobilization was (14.3±5.2) months. During the follow-up period, there was no significant limitation on the hip joint activity in the children. At the end of the follow-up, the Stulberg classification results showed that 66.7% were excellent, 22.2% were good, and 11.1% were poor. The follow-up results showed that children under the age of 6 with Catteral type 1 or type 2 had excellent or good Stulberg classification after treatment, while children over the age of 6 with Catteral type 3 or type 4 generally had poor Stulberg classification. However, it was possible to obtain good Stulberg classification results after prolonged treatment with Baylor plaster immobilization. Conclusion: Long-term Baylor plaster immobilization can effectively treat Perthes disease in children.

Key words:

"> font-size:10.5pt, ">Baylor plaster, children, Legg-Calve-Perthes disease

CLC Number: